M&T Bank Corp Royalty Pharma PLC Transaction History

M&T Bank Corp

$28.9 Billion
Q3 2025

A detailed history of M&T Bank Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, M&T Bank Corp holds 23,062 shares of RPRX stock, worth $903,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,062

Previous 25,816 10.67%

Holding current value

$903,107

Previous $930,000 12.58%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$34.9 - $37.91 $96,114 - $104,404	-2,754 Reduced 10.67%	23,062 $813,000
Q2 2025 Aug 13, 2025	SELL	$30.85 - $36.14 $97,208 - $113,877	-3,151 Reduced 10.88%	25,816 $930,000
Q1 2025 Apr 30, 2025	BUY	$25.75 - $33.86 $141,625 - $186,230	5,500 Added 23.44%	28,967 $901,000
Q4 2024 Feb 06, 2025	BUY	$24.28 - $28.39 $114,553 - $133,944	4,718 Added 25.16%	23,467 $598,000
Q3 2024 Nov 15, 2024	BUY	$25.63 - $29.27 $19,965 - $22,801	779 Added 4.34%	18,749 $530,000

Q2 2024 Jul 31, 2024	BUY	$26.26 - $29.9 $12,683 - $14,441	483 Added 2.76%	17,970 $473,000
Q1 2024 May 07, 2024	SELL	$27.46 - $31.33 $28,640 - $32,677	-1,043 Reduced 5.63%	17,487 $531,000
Q4 2023 Feb 06, 2024	BUY	$26.21 - $29.22 $57,006 - $63,553	2,175 Added 13.3%	18,530 $520,000
Q3 2023 Nov 02, 2023	BUY	$26.26 - $31.38 $44,694 - $53,408	1,702 Added 11.62%	16,355 $443,000
Q2 2023 Aug 09, 2023	BUY	$29.6 - $36.56 $12,520 - $15,464	423 Added 2.97%	14,653 $450,000
Q1 2023 May 11, 2023	SELL	$32.77 - $39.4 $149,398 - $179,624	-4,559 Reduced 24.26%	14,230 $512,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $58,676 - $65,971	1,498 Added 8.66%	18,789 $742,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $259,305 - $291,544	6,620 Added 62.04%	17,291 $683,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $10,328 - $11,564	259 Added 2.49%	10,671 $428,000
Q2 2022 Aug 05, 2022	BUY	$37.53 - $44.22 $117,056 - $137,922	3,119 Added 42.77%	10,412 $437,000
Q1 2022 May 09, 2022	SELL	$37.46 - $42.44 $134,781 - $152,699	-3,598 Reduced 33.04%	7,293 $283,000
Q4 2021 Feb 07, 2022	BUY	$35.17 - $42.48 $808 - $977	23 Added 0.21%	10,891 $433,000
Q3 2021 Oct 28, 2021	SELL	$36.14 - $42.24 $69,497 - $81,227	-1,923 Reduced 15.03%	10,868 $393,000
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $20,961 - $24,527	526 Added 4.29%	12,791 $524,000
Q1 2021 May 06, 2021	BUY	$42.34 - $52.82 $154,159 - $192,317	3,641 Added 42.22%	12,265 $535,000
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $311,498 - $431,631	8,624 New	8,624 $431,000

Others Institutions Holding RPRX

# of Institutions

534

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account